CHRF Receives Wellcome Discovery Award to Study RSV Infections


Child Health Research Foundation (CHRF)

Published on 4th March 2026

Read this email in your browser

CHRF Receives Wellcome Discovery Award to Study Severe RSV Infections in Children

We are thrilled to share that the Child Health Research Foundation (CHRF), Bangladesh, has received the prestigious Wellcome Discovery Award!

Building on CHRF’s surveillance platforms, this project brings together single-cell genomics, air–liquid interface cell culture models, flow cytometry, and risk factor analysis across community and hospital cohorts in Bangladesh to understand why RSV becomes severe in some children.

The Wellcome Discovery Award is provided by Wellcome, a UK–based charitable foundation. This highly competitive funding programme supports ambitious, curiosity-driven research into the fundamental biology of health and disease.

Read our press release here!

This is More Than a Grant. It is a Milestone for Bangladesh!

This project advances our mission to generate evidence that improves child health in Bangladesh and globally. To our knowledge, CHRF is the first South Asian institution to receive a Wellcome Discovery Award as the lead applicant. For a Bangladeshi, non-profit research organisation built patiently over years by local scientists, clinicians, trainees, nurses, lab technologists, and community workers, this moment belongs to many.

From sequencing the first SARS-CoV-2 genome in Bangladesh, to building surveillance systems for infectious diseases like sepsis, typhoid and RSV, to reaching thousands of young scientists through Building Scientists for Bangladesh, this award reflects a shared journey toward science that is done in Bangladesh, by Bangladesh, for the children of Bangladesh.

And now, we take the next step.

Why RSV, Why Now?

Respiratory Syncytial Virus (RSV) is one of the leading causes of severe pneumonia in infants and young children in Bangladesh. During peak seasons, hospitals fill with babies struggling to breathe. Yet we still do not fully understand why some children become critically ill while others recover quickly.

Through this Wellcome Discovery project, in the next 7 years we will examine how RSV infection, the child’s immune response, and environmental exposures shape the nasal mucosa and influence disease severity. By studying infection at single-cell resolution, we aim to advance our understanding of the full disease spectrum ranging from common cold to severe pneumonia. We also hope to uncover biological insights that guide vaccines, therapies, and public health policy for children in Bangladesh and globally.

This work connects directly to CHRF’s long-term RSV surveillance studies and our commitment to using data to improve child health.

A Collaboration Built on Respect and Shared Science

We are honoured to strengthen our existing partnership with Boston Children’s Hospital. Together, we bring expertise in single-cell genomics, mucosal immunology, respiratory biology, and field epidemiology. Just as important, this collaboration reflects a shared belief that cutting-edge science should be led from the places most affected by disease.

Knowledge will flow both ways. Trainees will train together. Data will be analysed together. Discoveries will be shared together.

This is what equitable global science looks like.

With Gratitude

This achievement belongs to our CHRF family, our laboratory teams, clinicians, field workers, data scientists, trainees, collaborators, and the families who trust us with their children’s samples and stories.

Many of you have walked with us through long nights in the lab, impossible grant deadlines, travel disruptions, and the everyday challenges of building science in resource-limited settings. This award carries your fingerprints.

We are also deeply grateful to the Wellcome Trust for believing in locally led science in Bangladesh.

Looking Forward

There is still much work ahead. RSV continues to hospitalise children. Pneumonia remains a leading cause of child mortality. But today, we celebrate a step forward.

From Dhaka to Mirzapur, from classrooms in Building Scientists for Bangladesh camps to sequencing runs in our labs, this project reminds us why we do science.

For curiosity.
For equity.
For children.

At CHRF, the best is yet to come.

Onward, with purpose and passion,
The CHRF Team

Thank you for reading!
We're always looking for feedback; email us at info@chrfbd.org

If you are reading this for the first time, consider subscribing!

Please forward this email to your friends and colleagues.
Unsubscribe · Preferences

CHRF

Read more from CHRF

Child Health Research Foundation (CHRF) Published on 10th March 2026 Read this email in your browser Celebrating International Women's Day by investing in the futures of five remarkable young girls This International Women’s Day, we chose to celebrate in a way that reflects what we believe in most: investing in the next generation. This year, CHRF is proud to support the dreams of five remarkable young girls, the daughters of our dedicated community health workers. For more than a decade...

Child Health Research Foundation (CHRF) Published on 12th October 2025 Read this email in your browser From Data to Arms: Typhoid Conjugate Vaccine Rolls Out Today in Bangladesh!A story of science, partnership, and hope. From Senjuti Saha, PhD, MPH Today is an extraordinary day for Bangladesh. For decades, we have collected data, built evidence, and pushed for action. This morning, those numbers turn into protection for millions of children as the typhoid conjugate vaccine reaches their arms....

Child Health Research Foundation Published on May 22, 2025 Read this email in your browser We are proud to share our latest publication in The Lancet Global Health, which sheds light on the immense burden of Respiratory Syncytial Virus (RSV) on children in low-resource settings. This study goes beyond the virus itself—it exposes the heartbreaking reality of hospital bed shortages and the lives lost as a result. It also offers hope: a glimpse of what health care could be when preventable...